Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)
暂无分享,去创建一个
H. Döhner | P. Vyas | O. Frankfurt | H. Kantarjian | G. Martinelli | C. Dinardo | R. Stone | A. Fathi | A. Zeidan | A. Schuh | E. Raffoux | S. Botton | E. Stein | A. Stein | P. Tan | T. Winkler | S. Daigle | J. Gong | D. Hickman | Xiwei Wang | D. Lam | V. Zhang | S. Kapsalis